🟢 InnovAge is trading 8.47% up in pre-market after first-quarter results beat expectations

InnovAge is trading at $9.60, up 8.47%, after fiscal first-quarter results beat expectations.

• Results released November 3 included revenue of $264.8 million, up 12.1% year over year, and earnings of $0.14 per share versus $0.11 expected.
• Adjusted EBITDA grew more than 75%, while census rose 6.7% to 8,420 participants.
• Management reaffirmed fiscal 2027 revenue guidance of $1.05 billion–$1.085 billion; a broader healthcare pre-market rally may also support the move.